Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ranbaxy: Rivals Meddling With Daiichi Sankyo Deal; Congress Enters Fray

This article was originally published in The Pink Sheet Daily

Executive Summary

CEO Singh goes on TV to say global pharma industry trying to scuttle his deal.

You may also be interested in...



Ranbaxy Sees Light At The End Of DoJ Investigation Tunnel

Information Ranbaxy is giving FDA will clear its name, CEO says.

Ranbaxy Sees Light At The End Of DoJ Investigation Tunnel

Information Ranbaxy is giving FDA will clear its name, CEO says.

Ranbaxy Denies Fraudulent Conduct Alleged By U.S. FDA As Rumors Swirl About Daiichi Deal

Ranbaxy has denied U.S. FDA allegations that it conducted "systematic fraudulent conduct" related to concealing violations of current good manufacturing practices

Topics

UsernamePublicRestriction

Register

ID001014

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel